Bill Type
Congress Name
Full Title of Bill
AN ACT STRENGTHENING THE REGULATORY SYSTEM IN THE COUNTRY TO COMBAT COUNTERFEIT PHARMACEUTICAL PRODUCTS, DECLARING THE MANUFACTURE, IMPORTATION, DISTRIBUTION, SALE OR OFFER FOR SALE, OR POSSESSION OF COUNTERFEIT PHARMACEUTICAL PRODUCTS AS AN OFFENSE INVOLVING ECONOMIC SABOTAGE, PROVIDING FOR THE PROHIBITIONS AND PENALTIES FOR VIOLATIONS AND REVISING FOR THE PURPOSE REPUBLIC ACT NO. 8203 OR THE "SPECIAL LAW ON COUNTERFEIT DRUGS".
Text as filed (link)
Date filed
November 24, 2022
Date Read
November 28, 2022
Bill Status
Referred to the Technical Working Group (TWG) on 2022-11-29
Committee Details
Primary Committee
Legislative History
| House Bill/Resolution NO. HB06342 | |
| FULL TITLE : AN ACT STRENGTHENING THE REGULATORY SYSTEM IN THE COUNTRY TO COMBAT COUNTERFEIT PHARMACEUTICAL PRODUCTS, DECLARING THE MANUFACTURE, IMPORTATION, DISTRIBUTION, SALE OR OFFER FOR SALE, OR POSSESSION OF COUNTERFEIT PHARMACEUTICAL PRODUCTS AS AN OFFENSE INVOLVING ECONOMIC SABOTAGE, PROVIDING FOR THE PROHIBITIONS AND PENALTIES FOR VIOLATIONS AND REVISING FOR THE PURPOSE REPUBLIC ACT NO. 8203 OR THE "SPECIAL LAW ON COUNTERFEIT DRUGS". | |
| PRINCIPAL AUTHOR/S : GATO, CIRIACO JR. B. | |
| DATE FILED : 2022-11-24 | |
| SIGNIFICANCE: NATIONAL | |
| CO-AUTHORS (Journal Entries) : | |
| 1. Bulut-Begtang (000 2022-12-14) | 2. Violago (000 2023-02-06) |
| 3. Barba (000 2023-03-21) | |
| ACTIONS TAKEN BY THE COMMITTEE ON RULES | |
| REFERRAL TO THE COMMITTEE ON HEALTH ON 2022-11-28 |
Significance